• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate
Neohesperidin
Advantame
Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench
Pharma and Food Grade, USP/FCC Neotame Sweetener E961
Trilobatin

EMA unveils business continuity plan ahead of UK exit from EU

firstwordpharmaAugust 02, 2017

Tag: EMA , UK , EU

The European Medicines Agency on Tuesday revealed its business continuity plan ahead of its relocation from the UK as part of the country's decision to leave the EU. As part of the initiative, the EMA indicated that it will be reallocating its resources to maintain higher-priority activities over the coming years. EMA's head of the Brexit task force Noel Wathion commented "preparing for the move, managing the necessary changes, and addressing challenges such as possible losses in skilled and experienced staff, in a proactive and efficient way requires considerable internal resources."

Previous:Lonza starts construction of Biological Development and Manufacturing Complex

Next:AbbVie receives EC grant to market HCV treatment Maviret

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

EMA unveils business continuity plan ahead of UK exit from EU | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

You may like
More>>

Factory supply high quality Hot sale 99% Methyl isoeugel CAS 93-16-3 with best price for sale

Factory supply high quality Hot sale 99% Methyl isoeugel CAS 93-16-3 with best price for sale
L-Arginine,L-arginyl-L-leucyl-L-cystein

L-Arginine,L-arginyl-L-leucyl-L-cystein
Pharmaceutical batching kettle 2

Pharmaceutical batching kettle 2
(S)-N-(METHOXYCARBONYL)-TERT-LEUCINE

(S)-N-(METHOXYCARBONYL)-TERT-LEUCINE
A107 Orientated Wrap-around Labeling System with Pneumatic Arm

A107 Orientated Wrap-around Labeling System with Pneumatic Arm
Leuprorelin

Leuprorelin
Soybean oil 10%~40%Plant extract Pharmaceutical made in china

Soybean oil 10%~40%Plant extract Pharmaceutical made in china
EUROSTAR 100 control P4

EUROSTAR 100 control P4
Wood-based Activated Carbon for Injection&Pharmaceutical Industry

Wood-based Activated Carbon for Injection&Pharmaceutical Industry
Eucalyptus Oil

Eucalyptus Oil

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service